SGAC at the 2012 International AIDS Conference

From July 22-27 2012, SGAC was at the International AIDS Conference. Amirah & Mel really enjoyed meeting everyone who visited. For those of you who weren't able to attend, here's what our booth looked like (with a bunch of SGACers tired out from the We Can End AIDS March hanging out in front!): Check out the rest of the pictures in our facebook album! Materials we used at AIDS 2012 Check out the following materials to get a sense of what SGAC did at the International AIDS Conference. Play the game! Points mean prizes (probably). Help us make noise and hold leaders accountable! Can you help us get 500 young people to the We Can End AIDS March? Stop by our booth to pick up a hard copy and please share this image! Schedule

Launch of the US Robin Hood Tax Campaign

On Tuesday, July 19th, the US Robin Hood Tax Campaign launched, with several of our members participating in rallies in NYC and Boston! Check out our campaign page for more information about the Robin Hood Tax. 

SGACers in Action at the 25th Anniversary of Act UP NY!

From ACT UP NY On April 25, over 1000 demonstrators gathered in New York to call for a tax on Wall Street to end AIDS. The protest also marked the 25th anniversary of ACT UP NY. SGAC was proud to march with such inspiring and accomplished AIDS activists to call for health and economic justice!   SGACers from New York City as well as Boston made it down for the rally and march. Check out more information and awesome photographs from POZ magazine.

2012 SGAC Conference Highlights

SGACers at the opening speech of the conference The 2012 SGAC conference, hosted at Columbia University in New York City, was a great success! We brought together over 70 student leaders (from chapters as far away as Iowa and Florida!) for a weekend of trainings, brainstorming, and bonding. Check out some of the highlights from this year's conference: student-led discussion and planning groups about trade policies, Financial Transaction Tax proposals, the Global Fund and PEPFAR, and syringe exchange ban reversal a workshop about intersectionality led by QUEEROCRACY interactive workshops about telling our stories, media training, and bird-dogging  

SGAC at the Republican Debate in Dartmouth

Check out photos from the action on Facebook On October 11th 2011, members of the Student Global AIDS Campaign and our allies marched to the doors of the Republican Debate at Dartmouth College to demand that each candidate release a comprehensive plan to end AIDS. We marched through the buildings where the candidates' campaigns were meeting, to make sure they heard our message directly. We dropped a giant banner from the roof of the building across the street. We held multiple "die-ins" across campus, to highlight the real consequences of inaction on AIDS. We went to events for every candidate and raised this issue, garnering press coverage from the Wall Street Journal, MSNBC, the Boston Herald, and at least six other media outlets.And perhaps most excitingly, after being questioned repeatedly by students in the lead-up to the debate, five of the candidates responded to students' demands to fund global AIDS programs. Their answers ranged from "we'll see" to "we need to protect foreign aid from cuts", which shows how far we've come from the days when candidates said flat-out "no, we have to cut funding for everything".

Who is SGAC? Video

Check out this video of SGAC superstars: Continue reading

Join the Virtual Vigil

SGAC is launching a "virtual vigil". We want to get 5,000 people to submit photos of themselves holding up signs or candles, and we'll bring them to our leaders and demand that they end AIDS. You can see the full album of pictures here.

New Photos of SGACers In Action

The New School Queerocracy (an SGAC affiliate) held a Valentine's Day Rally to raise awareness about the growing waiting lists for AIDS treatment in the US and worldwide. Click above for more photos on Facebook!

SGAC Winter 2011 Conference was a huge success!

Thanks to everyone who came out for the 2011 Winter Conference in Boston, MA. We had nearly 80 participants from 16 different schools across the country.

Don't let Pharma & Europe lock away new HIV meds

Five million people worldwide have access to HIV treatment, thanks in large part to the availability of cheap generic medication produced in India. India has a history of standing up to Big Pharma, and supporting access to life-saving generic medication. But right now, India is being pushed by Pharma and the European Union to sign a Free Trade Agreement (FTA) that would expand protections for pharmaceutical companies and hinder production of new generic HIV medications. [1] Not only would this agreement have disastrous consequences for the lives of millions of people around the world who rely on generic medication - it would severely hinder the US global AIDS program (PEPFAR). Generics, mostly from India, account for 75% of the HIV treatments purchased by the US government.Will you email the US Ambassador to India Timothy Roemer and ask him to encourage Indian Prime Minister Singh to continue to fight for access to medicine? Because the US government purchases mostly generic medication instead of expensive name-brand medication, PEPFAR has saved over $325 million from 2003-2008, according to a State Department report. [2] So, not only would the EU-India FTA virtually eliminate the chance of ensuring access to treatment for everyone with HIV, it would also cost the US government significantly more to continue providing treatment to those we're already supporting. India is deciding whether or not to agree to expanded protections for Big Pharma in the next few days, so please email Ambassador Roemer now.Here's how the EU-India FTA would limit generic availability - Generic drug companies demonstrate that their products are identical to brand-name companies' products, and then rely on brand name companies' drug trials to show their drugs are safe and effective. 'Data exclusivity' prevents generic companies from doing this by making it illegal for them to use the safety data already generated by the brand-name companies; instead, generic companies are forced to redo the clinical trials, which is prohibitively expensive, medically unethical, and delays access to treatment. The EU-India FTA sets the period of 'data exclusivity' at ten years. So, for the decade until the 'data exclusivity' on each new medication expires, important new, less-toxic HIV medications (which are widely available in the US) will simply be priced out of reach of millions who need them. India doesn't have to agree to this! Please email Ambassador Roemer now, and then forward this email to your friends and ask them to join you in taking action. Thank you! Sources: [1] Indian Prime Minister must resist European pressure to trade away health, Doctors Without Borders/MSF [2] Use of Generic Antiretroviral Drugs and Cost Savings in US HIV Treatment Programs, US Department of State